• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Adenylyl cyclase-associated protein 2 (CAP2)

ACP23785

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP23785 Target NameCAP2
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range2-477Protein LengthFull Length of Mature Protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP40123
Background Information
  • Uniprot Id

    P40123

  • Target Species

    Human

  • Target Name

    CAP2

  • Target Full Name

    Adenylyl cyclase-associated protein 2

  • Target Function

    May have a regulatory bifunctional role.

  • Target Subcellular Location

    Cell membrane; Peripheral membrane protein.

  • Target Protein Families

    CAP family

  • Target Synonyms

    2810452G09Rik; adenylate cyclase associated protein 2; Adenylyl cyclase associated protein 2; Adenylyl cyclase-associated protein 2; CAP 2; CAP adenylate cyclase associated protein 2; CAP adenylate cyclase-associated protein 2; CAP; adenylate cyclase associated protein; 2 (yeast); cap2; CAP2_HUMAN

  • Target Background

    This gene was identified by its similarity to the gene for human adenylyl cyclase-associated protein. The function of the protein encoded by this gene is unknown. However, the protein appears to be able to interact with adenylyl cyclase-associated protein and actin.

Inquire Recombinant Human Adenylyl cyclase-associated protein 2 (CAP2) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification